Live data — every record is aggregated from real public sources. VialGrade never sells; it links out to the vendor.
VialGrade
All compounds
GLP-1 / metabolic
Live data

Liraglutide

Weight & metabolic

An earlier daily GLP-1 analog (Victoza/Saxenda) studied in metabolic and weight research.

VictozaSaxendaNN2211

Get told when a price moves or a lab test changes.

Observed median price

$51

Δ —
Every observation
DateObserved
$50.60
$50.60
$50.60
$50.60
$50.60
$50.60

Not enough listings with 30 days of checks to summarise a change — 0 of 5 qualify so far.

5

Active listings

0

Independent lab tests

$44–$86

Observed price range

4

Known aliases

Understand this compound

What is Liraglutide?

FDA-approved moleculea.k.a. Saxenda, Victoza

The earlier, once-daily cousin of Ozempic — a lab-made version of a gut fullness hormone, approved for diabetes as Victoza and for weight loss as Saxenda.

Weight & metabolic
⚠

Good to know: Requires daily injection (shorter-acting than newer weekly agents); labeling notes GI effects and rare pancreatitis/thyroid C-cell tumor signals from animal studies.

How does Liraglutide work?

The science

A GLP-1 receptor agonist with 97% sequence homology to native GLP-1; stimulates insulin secretion, suppresses glucagon, slows gastric emptying, and promotes satiety.

Mechanism of action from published research — how the molecule behaves, not a claim about any product or any human-use effect.

What is Liraglutide researched for?

Studied for type-2 diabetes and chronic weight management (obesity), including in pediatric populations.

  • Weight & metabolicStudied in weight, appetite, blood-sugar, and fat-metabolism research.
How far has the research gone?

FDA-approved (for type-2 diabetes and obesity); approved as Victoza (2010) and Saxenda (2014).

Where the science stands — an approved drug is not the same as the research-grade material a vendor sells, which is unregulated regardless.

What should I check before buying?
  • Independent purity. Look for a third-party COA (Janoshik or MZ) showing a measured purity — not just a number the vendor typed.
  • Batch match. The strongest evidence is a certificate for the exact batch you’ll receive, attributed to this vendor — check the cross-verification on the listing.
  • Vendor reputation. See how the vendor is talked about in the community before trusting a new name.

Research context only — VialGrade never gives dosing, medical, or human-use guidance.

Current market

The Liraglutide market

Every Liraglutide listing we track — 5 in all. The standout picks first where the evidence supports them, then the full table, ranked by what a milligram really costs wherever the vendor published a strength we can read.

Open full market

Compare by real cost

Every Liraglutide listing, cheapest per mg first

Sticker prices hide the size, so listings are ranked by what a milligram actually costs — with independently tested purity where it exists. All 5 are here: the last 1 is a listing whose vendor never published a strength we can read, so it has no per-mg figure to sort on.

#VendorSizePricePer mgTested purityReal $/active mg
1PurerawzUnavailable5mg total$86$17.2/mg——View
2PurerawzUnavailable3mg totalSublingual Tablets · 30mcg per tablet/100ct/3mg each$73$24.4/mg——View
3PurerawzUnavailable1mg totalSublingual Tablets · 10mcg per tablet/100ct/1mg each$44$43.9/mg——View
4PurerawzUnavailable1mg total$54$53.8/mg——View
Listed, but not rankable — no published strength to price per mg
—PurerawzUnavailableNasal Spray · 10mcg per spray/1mg$47no size published——View

Open the full Liraglutide market

Real $/active mg divides the price-per-mg by the measured purity — the honest cost of the actual peptide, so a 90%-pure vial isn’t compared as if it were 99%. Too cheap? flags a listing far below the market rate — often underdosing or a fake, not a deal. The crown marks the cheapest non-outlier; best value marks the lowest real cost per active mg. A vendor shown as Unavailable or Low stock is priced here but not currently buyable.

What the research says

Scientific evidence & regulatory status

What the published literature actually shows about Liraglutide — separate from any vendor’s marketing. Each finding links to its paper. This is education, not medical or dosing advice.

Regulatory status

An approved drug exists — this is not it

FDA-approved as Victoza (2010) for type 2 diabetes and Saxenda (2014) for chronic weight management, with generic liraglutide approved since; the EMA has authorized both. These are prescription injectables — research-grade liraglutide sold online is not an approved product.

US legal status

This is a prescription drug in the US

This is the active drug in Victoza and Saxenda — an FDA-approved prescription medication. Buying a “research” version sidesteps the prescription requirement and the approved, quality-controlled supply chain. The FDA has warned about and acted against unapproved and compounded copies. Higher legal and safety exposure than an unapproved research peptide.

Read the full US law →

General information, not legal or medical advice. VialGrade sells nothing and encourages no human use.

Research notes aren’t product proof

Research summaries describe published literature and market data only. They do not establish the identity, quality, safety, or legal status of any listed physical product.